Table 4. Frequency of KIR-HLA combinations in UC, CD, and control subjects.
| KIR-HLA | UC (n = 90) |
CD (n = 50) |
Controls (n = 325) |
UC vs. Controls | CD vs. Controls | ||
|---|---|---|---|---|---|---|---|
| P | OR (95% CI) | P | OR (95% CI) | ||||
| 3DL1-Bw4 | 62 (69%) | 31 (62%) | 135 (42%) | 4.3×10−6 | 3.12 (1.89–5.13) | 0.0067 | 2.30 (1.24–4.24) |
| 3DS1-Bw4 | 22 (24%) | 11 (22%) | 50 (15%) | 0.045 | 1.78 (1.01–3.14) | 0.24 | - |
| 2DL1-C2 | 10 (11%) | 8 (16%) | 68 (21%) | 0.035 | 0.47 (0.23–0.96) | 0.42 | - |
| 2DS1-C2 | 5 (6%) | 4 (8%) | 26 (8%) | 0.57 | - | 0.78 | - |
| 2DL2-C1 | 11 (12%) | 10 (20%) | 47 (14%) | 0.59 | - | 0.31 | - |
| 2DL3-C1 | 89 (99%) | 49 (98%) | 324 (100%) | 0.91 | - | 0.63 | - |
| 2DS2-C1 | 12 (13%) | 11 (22%) | 53 (16%) | 0.49 | - | 0.32 | - |